QA: IntelGenx Technologies Corp. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2023_IntelGenx_Technologies_Corp.pdf

Logs

Graph

Absolute values for 0001098880, IntelGenx Technologies Corp.

  xvar xval
0 AssetsCurrent 3,788,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,425,000
3 remainder_Assets 977,000
4 LiabilitiesCurrent 2,374,000
5 LiabilitiesNoncurrent 425,000
6 remainder_Liabilities 9,814,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,697,000
9 ResearchAndDevelopmentExpense 3,031,000
10 remainder_Expenses 2,635,000
11 remainder_Revenues 950,000
12 remainder_NetIncome -1,277,000
13 remainder_ComprehensiveNetIncome -863,000
  yvar yval
0 Assets 9,190,000
1 Liabilities 12,613,000
2 Expenses 10,363,000
3 Revenues 950,000
4 StockholdersEquity -3,423,000
5 NetIncome -10,690,000
6 ComprehensiveNetIncome -11,121,500
7 BaseVar 17,628,000
8 EconomicCapitalRatio -1.56

Edgar->Model Mapping

Feature Distribution

Change over Time